Advertisement
Screener

Atreca, Inc. Patents: Applications Rejected

Atreca, Inc. Patent Applications Rejected

8 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-04-22: Application 18703646; Invention ANTIBODIES TO CORONAVIRUS SARS-COV-2; Applicant Atreca, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2022-09-26: Application 17935152; Invention ANTIBODIES THAT BIND TUMOR TISSUE FOR DIAGNOSIS AND THERAPY; Applicant Atreca, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2022-07-19: Application 17759091; Invention HIGH THROUGHPUT LINKING OF MULTIPLE TRANSCRIPTS; Applicant ATRECA, INC.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2022-01-31: Application 17588829; Invention USE OF NANOEXPRESSION TO INTERROGATE ANTIBODY REPERTOIRES; Applicant ATRECA, INC.; Status Abandoned -- Failure to Respond to an Office Action.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2024-04-2218703646ANTIBODIES TO CORONAVIRUS SARS-COV-2Atreca, Inc.
University of Vermont and State Agricultural College
Abandoned -- Failure to Respond to an Office ActionUS20240327505A1
Jason Botten
Katherine L. Williams
Ngan Nguyen Atkins
Annalis Whitaker
United States
United States
United States
United States
SZPERKA, MICHAEL EDWARD
2022-09-2617935152ANTIBODIES THAT BIND TUMOR TISSUE FOR DIAGNOSIS AND THERAPYAtreca, Inc.Abandoned -- Failure to Respond to an Office ActionUS20230140035A1
Jeff DeFalco
Daniel Eric Emerling
Jessica Finn
Norman Michael Greenberg
Vera Huang
Shaun M. Lippow
Fengling Liu
Amy Manning-Bog
William H. Robinson
Alexander Scholz
Tito Serafini
Nikhil Vad
Wayne Volkmuth
Yann Chong TAN
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
ALSOMAIRY, SARAH ABDOALATIF
2022-07-1917759091HIGH THROUGHPUT LINKING OF MULTIPLE TRANSCRIPTSATRECA, INC.Abandoned -- Failure to Respond to an Office ActionUS20230220376A1
Sean CARROLL
Gary WITHEY
Sergey BOYARSKIY
United States
United States
United States
FLINDERS, JEREMY C
2022-01-3117588829USE OF NANOEXPRESSION TO INTERROGATE ANTIBODY REPERTOIRESATRECA, INC.Abandoned -- Failure to Respond to an Office ActionUS20220155319A1
Jeff DeFALCO
Daniel EMERLING
Shaun LIPPOW
Sean CARROLL
Wayne VOLKMUTH
Norm GREENBERG
Tito SERAFINI
United States
United States
United States
United States
United States
United States
United States
BOESEN, CHRISTIAN C
2021-08-1917432185ANTI-CSP ANTIBODY VARIANTSAtreca, Inc.Abandoned -- Failure to Respond to an Office ActionUS20220195023A1
Shaun M. Lippow
United States
XIE, XIAOZHEN
2021-07-2817443909COMBINATORIAL SETS OF NUCLEIC ACID BARCODES FOR ANALYSIS OF NUCLEIC ACIDS ASSOCIATED WITH SINGLE CELLSATRECA, INC.Abandoned -- Failure to Respond to an Office ActionUS20210380974A1
Gary WITHEY
United States
LAFAVE, ELIZABETH ROSE
2020-04-0916844088USE OF NANOEXPRESSION TO INTERROGATE ANTIBODY REPERTOIRESATRECA, INC.Abandoned -- Failure to Respond to an Office ActionUS20200355698A1
Jeff DeFalco
Daniel Emerling
Shaun Lippow
Sean Carroll
Wayne Volkmuth
Norm Greenberg
Tito Serafini
United States
United States
United States
United States
United States
United States
United States
BOESEN, CHRISTIAN C
2014-06-3014319489Use of Nanoexpression to Interrogate Antigen RepertoiresAtreca, Inc.Abandoned -- Failure to Respond to an Office ActionUS20150011405A1
Shaun Lippow
Jeff DeFalco
Daniel Emerling
Sean Carroll
Wayne Volkmuth
Norm Greenberg
Tito Serafini
United States
United States
United States
United States
United States
United States
United States
BOESEN, CHRISTIAN C